Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
Risk Prediction for Hypertension, Elevated Plasma Triglyceride and Metabolic Syndrome: Elucidation of A Common LPL Haplotype More
Genetic Association of Familial Combined Hyperlipidaemia for Diagnostic and Pharmacogenomic uses More
Detection of Cytochrome P450 (CYP) 2D7-CYP2D6 Recombinant Genes: Use in Pharmacogenomic Drug Testing in Patients More
Elucidation of Liver-Secreted Factor of 4 Kda (Lsf4): Implicated in Cholesterol and Obesity Related Diseases More
Compositions and Methods for Prognosis and Therapy of Liver Cancer More
Development of a Novel Method to Identify Edited mRNAs More
Haptoglobin Phenotyping to Predict the Risk of Diabetic Vascular Disease More
Acetaminophen Toxicity Pharmocogenomics: Elucidation of SNPs Associated with N-acetyl-p-benzoquinonimine Cytotoxicity More
A Small Interfering RNA as a Potent Inhibitor of Diverse Strains of HCV More
Obesity and Body Fat Distribution: Targets for Treatment of Obesity and Gene Expression Diagnosis of Obesity More
Related Reports
Market Research Reports provided by reports.iptechex.com
Mar 2011 - 20 pages - $250
Jun 2010 - 160 pages - $3,995
Jan 2011 - 99 pages - $3,835
Aug 2010 - 80 pages - $1,215
Aug 2007 - 87 pages - $1,999
Mar 2011 - 23 pages - $250
Mar 2011 - 14 pages - $750
Sep 2010 - 21 pages - $99
Sep 2009 - 167 pages - $4,650
Aug 2010 - 138 pages - $1,215
Your selection
Browse By
- Therapeutic target
- Anorexia
- Anti-oxidant
- Appetite
- Bulimia nervosa
- Cachexia
- Cirrhosis
- Diabetes type I
- Diabetes type II
- Diabetic complications
- Fabry's disease
- Gallbladder disorder (other)
- Gallstones
- Gaucher's disease
- Hepatic protectors
- Hepatic protectors
- Hypercholesterolemia
- Hyperparathyroidism
- Hypertriglyceridemia
- Liver cancer
- Liver disorders (other)
- Metabolic disorder (other)
- Mineral supplement
- Obesity
- Weight loss
- Development phase
- Early Stage
- Preclinical
- Phase I
- Phase I/II
- Phase II
- Phase III
- Phase III/IV
- Preregistration
- Registered
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us